Elopak ASA

OB:ELO Stock Report

Market Cap: NOK 11.2b

Elopak Future Growth

Future criteria checks 4/6

Elopak is forecast to grow earnings and revenue by 9.8% and 5.8% per annum respectively. EPS is expected to grow by 12.8% per annum. Return on equity is forecast to be 22.3% in 3 years.

Key information

9.8%

Earnings growth rate

12.8%

EPS growth rate

Packaging earnings growth18.2%
Revenue growth rate5.8%
Future return on equity22.3%
Analyst coverage

Low

Last updated13 Jan 2025

Recent future growth updates

Elopak ASA Just Missed Earnings - But Analysts Have Updated Their Models

Nov 02
Elopak ASA Just Missed Earnings - But Analysts Have Updated Their Models

Here's What Analysts Are Forecasting For Elopak ASA (OB:ELO) After Its Second-Quarter Results

Aug 18
Here's What Analysts Are Forecasting For Elopak ASA (OB:ELO) After Its Second-Quarter Results

Recent updates

Elopak ASA's (OB:ELO) Business Is Yet to Catch Up With Its Share Price

Jan 23
Elopak ASA's (OB:ELO) Business Is Yet to Catch Up With Its Share Price

Elopak ASA Just Missed Earnings - But Analysts Have Updated Their Models

Nov 02
Elopak ASA Just Missed Earnings - But Analysts Have Updated Their Models

Elopak's (OB:ELO) Returns On Capital Are Heading Higher

Oct 22
Elopak's (OB:ELO) Returns On Capital Are Heading Higher

Risks To Shareholder Returns Are Elevated At These Prices For Elopak ASA (OB:ELO)

Sep 14
Risks To Shareholder Returns Are Elevated At These Prices For Elopak ASA (OB:ELO)

Here's What Analysts Are Forecasting For Elopak ASA (OB:ELO) After Its Second-Quarter Results

Aug 18
Here's What Analysts Are Forecasting For Elopak ASA (OB:ELO) After Its Second-Quarter Results

Returns On Capital Are Showing Encouraging Signs At Elopak (OB:ELO)

Jul 18
Returns On Capital Are Showing Encouraging Signs At Elopak (OB:ELO)

Is Elopak (OB:ELO) Using Too Much Debt?

May 13
Is Elopak (OB:ELO) Using Too Much Debt?

Elopak (OB:ELO) Is Increasing Its Dividend To €1.46

Apr 22
Elopak (OB:ELO) Is Increasing Its Dividend To €1.46

Shareholders Can Be Confident That Elopak's (OB:ELO) Earnings Are High Quality

Apr 18
Shareholders Can Be Confident That Elopak's (OB:ELO) Earnings Are High Quality

Elopak (OB:ELO) Has Announced That It Will Be Increasing Its Dividend To €1.46

Feb 26
Elopak (OB:ELO) Has Announced That It Will Be Increasing Its Dividend To €1.46

Elopak (OB:ELO) Is Looking To Continue Growing Its Returns On Capital

Feb 21
Elopak (OB:ELO) Is Looking To Continue Growing Its Returns On Capital

Is Elopak (OB:ELO) Using Too Much Debt?

Jan 25
Is Elopak (OB:ELO) Using Too Much Debt?

Elopak (OB:ELO) Might Have The Makings Of A Multi-Bagger

Nov 03
Elopak (OB:ELO) Might Have The Makings Of A Multi-Bagger

Earnings and Revenue Growth Forecasts

OB:ELO - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20271,37485N/A1991
12/31/20261,35492581605
12/31/20251,24776551565
12/31/20241,16370291475
9/30/20241,1606695144N/A
6/30/20241,15171153177N/A
3/31/20241,14174140142N/A
12/31/20231,13268157157N/A
9/30/20231,11266117107N/A
6/30/20231,101608679N/A
3/31/20231,081527877N/A
12/31/20221,024342525N/A
9/30/202297223350N/A
6/30/202291619455N/A
3/31/2022858173074N/A
12/31/2021855303673N/A
9/30/2021853365896N/A
6/30/2021847406195N/A
3/31/2021899433679N/A
12/31/20209094854104N/A
12/31/2019907103486N/A
12/31/201890428-738N/A
12/31/201791032N/A43N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ELO's forecast earnings growth (9.8% per year) is above the savings rate (2.4%).

Earnings vs Market: ELO's earnings (9.8% per year) are forecast to grow faster than the Norwegian market (9% per year).

High Growth Earnings: ELO's earnings are forecast to grow, but not significantly.

Revenue vs Market: ELO's revenue (5.8% per year) is forecast to grow faster than the Norwegian market (2% per year).

High Growth Revenue: ELO's revenue (5.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ELO's Return on Equity is forecast to be high in 3 years time (22.3%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/30 03:21
End of Day Share Price 2025/01/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Elopak ASA is covered by 7 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Justin JordanBNP Paribas Exane
Charlie Muir-SandsBNP Paribas Exane